The gold-standard HRD test1 now validated for local laboratories

Download the clinical summary

MyChoice CDx Plus is the first clinically validated HRD test to be used successfully in a decentralized setting. This milestone study potentially broadens access to crucial genetic insights for more patients worldwide, including in countries that prohibit central diagnostic procedures.

Fill out the form below to download your free copy of the Denkert clinical summary and learn more about this key validation study.

Denkert clinical summary screenshot_locked


  1. Miller, R.E. et al. “ESMO Recommendations On Predictive Biomarker Testing For Homologous Recombination Deficiency And PARP Inhibitor Benefit In Ovarian Cancer”. Annals Of Oncology, vol 31, no. 12, 2020, pp. 1606-1622.